These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 9477000

  • 1. The effects of sigma, PCP, and opiate receptor ligands in rats trained with ibogaine as a discriminative stimulus.
    Helsley S, Filipink RA, Bowen WD, Rabin RA, Winter JC.
    Pharmacol Biochem Behav; 1998 Feb; 59(2):495-503. PubMed ID: 9477000
    [Abstract] [Full Text] [Related]

  • 2. Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors.
    Mori A, Noda Y, Mamiya T, Miyamoto Y, Nakajima A, Furukawa H, Nabeshima T.
    Behav Brain Res; 2001 Feb 15; 119(1):33-40. PubMed ID: 11164523
    [Abstract] [Full Text] [Related]

  • 3. Drug discrimination studies with ibogaine.
    Helsley S, Rabin RA, Winter JC.
    Alkaloids Chem Biol; 2001 Feb 15; 56():63-77. PubMed ID: 11705117
    [Abstract] [Full Text] [Related]

  • 4. Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.
    Helsley S, Fiorella D, Rabin RA, Winter JC.
    Pharmacol Biochem Behav; 1998 Feb 15; 59(2):419-25. PubMed ID: 9476990
    [Abstract] [Full Text] [Related]

  • 5. Discriminative stimulus effects of the PCP/sigma-ligand (+)-N-allylnormetazocine in monkeys.
    Holtzman SG.
    Pharmacol Biochem Behav; 1993 Feb 15; 44(2):349-55. PubMed ID: 8446667
    [Abstract] [Full Text] [Related]

  • 6. Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus.
    Helsley S, Rabin RA, Winter JC.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Feb 15; 23(2):317-26. PubMed ID: 10368872
    [Abstract] [Full Text] [Related]

  • 7. Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat.
    Shearman GT, Herz A.
    Eur J Pharmacol; 1982 Aug 27; 82(3-4):167-72. PubMed ID: 6290235
    [Abstract] [Full Text] [Related]

  • 8. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE, Holtzman SG.
    J Pharmacol Exp Ther; 1986 May 27; 237(2):437-44. PubMed ID: 3009783
    [Abstract] [Full Text] [Related]

  • 9. Antagonism of a (+)N-allylnormetazocine stimulus by (-)PPAP and several structurally related analogs.
    Glennon RA, Young R, Herndon JL.
    Pharmacol Biochem Behav; 1993 Aug 27; 45(4):865-9. PubMed ID: 8105490
    [Abstract] [Full Text] [Related]

  • 10. Failure of ibogaine to produce phencyclidine-like discriminative stimulus effects in rats and monkeys.
    Jones HE, Li H, Balster RL.
    Pharmacol Biochem Behav; 1998 Feb 27; 59(2):413-8. PubMed ID: 9476989
    [Abstract] [Full Text] [Related]

  • 11. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA.
    J Pharmacol Exp Ther; 1996 Dec 27; 279(3):1130-41. PubMed ID: 8968334
    [Abstract] [Full Text] [Related]

  • 12. Sigma-1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa-opioid receptor agonist U-50488H.
    Mori T, Yoshizawa K, Nomura M, Isotani K, Torigoe K, Tsukiyama Y, Narita M, Suzuki T.
    Addict Biol; 2012 Jul 27; 17(4):717-24. PubMed ID: 21392175
    [Abstract] [Full Text] [Related]

  • 13. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
    Singh L, Wong EH, Kesingland AC, Tricklebank MD.
    Br J Pharmacol; 1990 Jan 27; 99(1):145-51. PubMed ID: 2158832
    [Abstract] [Full Text] [Related]

  • 14. Discriminative stimulus effects of dextromethorphan in the rat.
    Holtzman SG.
    Psychopharmacology (Berl); 1994 Nov 27; 116(3):249-54. PubMed ID: 7892413
    [Abstract] [Full Text] [Related]

  • 15. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds.
    Picker MJ.
    Behav Pharmacol; 1991 Dec 27; 2(6):497-511. PubMed ID: 11224092
    [Abstract] [Full Text] [Related]

  • 16. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.
    Itzhak Y, Ali SF.
    Ann N Y Acad Sci; 1998 May 30; 844():245-51. PubMed ID: 9668682
    [Abstract] [Full Text] [Related]

  • 17. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.
    Winter JC, Eckler JR, Rabin RA.
    Psychopharmacology (Berl); 2004 Mar 30; 172(2):233-40. PubMed ID: 14598016
    [Abstract] [Full Text] [Related]

  • 18. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH, Code RA.
    J Pharmacol Exp Ther; 1983 Dec 30; 227(3):563-9. PubMed ID: 6317838
    [Abstract] [Full Text] [Related]

  • 19. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.
    Halberstadt AL, Hyun J, Ruderman MA, Powell SB.
    Pharmacol Biochem Behav; 2016 Sep 30; 148():69-75. PubMed ID: 27236030
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE.
    J Pharmacol Exp Ther; 1983 Apr 30; 225(1):144-52. PubMed ID: 6834266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.